-
1
-
-
66449093193
-
Hyponatremia in the intensive care unit
-
10.1016/j.semnephrol.2009.03.003, 19523573
-
Palmer BF. Hyponatremia in the intensive care unit. Semin Nephrol 2009, 29:257-270. 10.1016/j.semnephrol.2009.03.003, 19523573.
-
(2009)
Semin Nephrol
, vol.29
, pp. 257-270
-
-
Palmer, B.F.1
-
2
-
-
0025152285
-
Incidence and etiology of hyponatremia in an intensive care unit
-
De Vita MV, Gardenswartz MH, Konecky A, Zabetakis PM. Incidence and etiology of hyponatremia in an intensive care unit. Clin Nephrol 1990, 34:163-166.
-
(1990)
Clin Nephrol
, vol.34
, pp. 163-166
-
-
De Vita, M.V.1
Gardenswartz, M.H.2
Konecky, A.3
Zabetakis, P.M.4
-
3
-
-
60549103075
-
The epidemiology of intensive care unit-acquired hyponatremia and hypernatremia in medical-surgical intensice care units
-
10.1186/cc7162, 2646327, 19094227
-
Stelfox MT, Ahmed SB, Khandwala F, Zygun D, Shahpori R, Lauplan K. The epidemiology of intensive care unit-acquired hyponatremia and hypernatremia in medical-surgical intensice care units. Crit Care 2008, 12:R162. 10.1186/cc7162, 2646327, 19094227.
-
(2008)
Crit Care
, vol.12
-
-
Stelfox, M.T.1
Ahmed, S.B.2
Khandwala, F.3
Zygun, D.4
Shahpori, R.5
Lauplan, K.6
-
4
-
-
76149146021
-
Impact of hospital-associated hyponatremia on selected outcomes
-
10.1001/archinternmed.2009.513, 20142578
-
Wald R, Jaber BL, Price LL, Upadhyay A, Madias NE. Impact of hospital-associated hyponatremia on selected outcomes. Arch Intern Med 2010, 170:294-302. 10.1001/archinternmed.2009.513, 20142578.
-
(2010)
Arch Intern Med
, vol.170
, pp. 294-302
-
-
Wald, R.1
Jaber, B.L.2
Price, L.L.3
Upadhyay, A.4
Madias, N.E.5
-
5
-
-
65249118223
-
The vaptans ante portas: a status report
-
10.1093/ndt/gfp034, 19218537
-
Gross P, Marczewski T, Herbrig K. The vaptans ante portas: a status report. Nephrol Dial Transplant 2009, 24:1371-1373. 10.1093/ndt/gfp034, 19218537.
-
(2009)
Nephrol Dial Transplant
, vol.24
, pp. 1371-1373
-
-
Gross, P.1
Marczewski, T.2
Herbrig, K.3
-
6
-
-
33846521902
-
Evaluation and management of hyponatremia: an emerging role for vasopressin receptor antagonists
-
10.1038/ncpneph0401, 17251996
-
Chen S, Jalandhara N, Battle D. Evaluation and management of hyponatremia: an emerging role for vasopressin receptor antagonists. Nat Clin Pract Nephrol 2007, 3:82-95. 10.1038/ncpneph0401, 17251996.
-
(2007)
Nat Clin Pract Nephrol
, vol.3
, pp. 82-95
-
-
Chen, S.1
Jalandhara, N.2
Battle, D.3
-
7
-
-
33646499848
-
Vaptans and the treatment of water-retaining disorders
-
10.1016/j.semnephrol.2006.02.003, 16713496
-
Quitbnat F, Gross P. Vaptans and the treatment of water-retaining disorders. Semin Nephrol 2006, 26:234-243. 10.1016/j.semnephrol.2006.02.003, 16713496.
-
(2006)
Semin Nephrol
, vol.26
, pp. 234-243
-
-
Quitbnat, F.1
Gross, P.2
-
8
-
-
33745093213
-
Vasopressin receptor antagonists
-
10.1038/sj.ki.5000432, 16672911
-
Greenberg A, Verbalis JG. Vasopressin receptor antagonists. Kidney Int 2006, 69:2124-2130. 10.1038/sj.ki.5000432, 16672911.
-
(2006)
Kidney Int
, vol.69
, pp. 2124-2130
-
-
Greenberg, A.1
Verbalis, J.G.2
-
9
-
-
43049146180
-
Non-peptide arginine-vasopressin antagonists: the vaptans
-
10.1016/S0140-6736(08)60695-9, 18468546
-
Decaux G, Soupart A, Vassart G. Non-peptide arginine-vasopressin antagonists: the vaptans. Lancet 2008, 371:1624-1632. 10.1016/S0140-6736(08)60695-9, 18468546.
-
(2008)
Lancet
, vol.371
, pp. 1624-1632
-
-
Decaux, G.1
Soupart, A.2
Vassart, G.3
-
10
-
-
33744963977
-
Efficacy and safety of oral conivaptan: a V1A/V2 vasopressin receptor antagonist, assessed in a randomized, placebo-controlled trial in patiens with euvolemic or hypervolemic hyponatremia
-
10.1210/jc.2005-2287, 16522696
-
Ghali JK, Koren MJ, Tayor JR, Brooks-Asplund E, Fan K, Long WA, Smith N. Efficacy and safety of oral conivaptan: a V1A/V2 vasopressin receptor antagonist, assessed in a randomized, placebo-controlled trial in patiens with euvolemic or hypervolemic hyponatremia. J Clin Endocrinol Metab 2006, 91:2145-2152. 10.1210/jc.2005-2287, 16522696.
-
(2006)
J Clin Endocrinol Metab
, vol.91
, pp. 2145-2152
-
-
Ghali, J.K.1
Koren, M.J.2
Tayor, J.R.3
Brooks-Asplund, E.4
Fan, K.5
Long, W.A.6
Smith, N.7
-
11
-
-
0035348291
-
Long-term treatment of patients with inappropriate secretion of antidiuretic hormone by the vasopressin receptor antagonist conivaptan, urea, or furosemide
-
10.1016/S0002-9343(01)00678-7, 11343672
-
Decaux G. Long-term treatment of patients with inappropriate secretion of antidiuretic hormone by the vasopressin receptor antagonist conivaptan, urea, or furosemide. Am J Med 2001, 110:582-584. 10.1016/S0002-9343(01)00678-7, 11343672.
-
(2001)
Am J Med
, vol.110
, pp. 582-584
-
-
Decaux, G.1
-
12
-
-
34748924247
-
Assessment of the efficacy and safety of intravenous conivaptan in euvolemic and hypervolemic hyponatremia
-
10.1159/000106456, 17664863, Conivaptan Study Group
-
Zeltser D, Rosansky S, van Rensburg H, Verbalis JG, Smith N, . Conivaptan Study Group Assessment of the efficacy and safety of intravenous conivaptan in euvolemic and hypervolemic hyponatremia. Am J Nephrol 2007, 27:447-457. 10.1159/000106456, 17664863, Conivaptan Study Group.
-
(2007)
Am J Nephrol
, vol.27
, pp. 447-457
-
-
Zeltser, D.1
Rosansky, S.2
van Rensburg, H.3
Verbalis, J.G.4
Smith, N.5
-
13
-
-
45349106231
-
Assessment of the efficacy and safety of intravenous conivaptan in patients with euvolaemic hyponatremia: subgroup analysis of a randomized, controlled study
-
10.1111/j.1365-2265.2007.03149.x, 18034777
-
Verbalis JG, Zeltser D, Smith N, Barve A, Andoh M. Assessment of the efficacy and safety of intravenous conivaptan in patients with euvolaemic hyponatremia: subgroup analysis of a randomized, controlled study. Clin Endocrinol (Oxf) 2008, 69:159-168. 10.1111/j.1365-2265.2007.03149.x, 18034777.
-
(2008)
Clin Endocrinol (Oxf)
, vol.69
, pp. 159-168
-
-
Verbalis, J.G.1
Zeltser, D.2
Smith, N.3
Barve, A.4
Andoh, M.5
-
14
-
-
62249203665
-
Efficacy and safety of oral conivaptan, a vasopressin-receptor antagonist, evaluated in a randomized, controlled trial in patients with euvolemic or hypervolemic hyponatremia
-
10.1097/MAJ.0b013e31817b8148, 19057376, Conivaptan Study Group
-
Ananne D, Decaux G, Smith N, . Conivaptan Study Group Efficacy and safety of oral conivaptan, a vasopressin-receptor antagonist, evaluated in a randomized, controlled trial in patients with euvolemic or hypervolemic hyponatremia. Am J Med Sci 2009, 337:28-36. 10.1097/MAJ.0b013e31817b8148, 19057376, Conivaptan Study Group.
-
(2009)
Am J Med Sci
, vol.337
, pp. 28-36
-
-
Ananne, D.1
Decaux, G.2
Smith, N.3
-
15
-
-
70349327412
-
Conivaptan bolus dosing for the correction of hyponatremia in the neurointensive care unit
-
10.1007/s12028-008-9179-3, 2820273, 19123060
-
Murphy T, Dhar R, Diringer M. Conivaptan bolus dosing for the correction of hyponatremia in the neurointensive care unit. Neurocrit Care 2009, 11:14-19. 10.1007/s12028-008-9179-3, 2820273, 19123060.
-
(2009)
Neurocrit Care
, vol.11
, pp. 14-19
-
-
Murphy, T.1
Dhar, R.2
Diringer, M.3
-
16
-
-
77951692168
-
Intravenous conivaptan for the treatment of hyponatremia caused by the syndrome of inappropriate secretion of antidiuretic hormone in hospitalized patients: a single-centre experience
-
10.1093/ndt/gfp731, 20064953
-
Velez JC, Dopson SJ, Sanders DS, Delay TA, Arthur JM. Intravenous conivaptan for the treatment of hyponatremia caused by the syndrome of inappropriate secretion of antidiuretic hormone in hospitalized patients: a single-centre experience. Nephrol Dial Transplant 2010, 25:1524-1531. 10.1093/ndt/gfp731, 20064953.
-
(2010)
Nephrol Dial Transplant
, vol.25
, pp. 1524-1531
-
-
Velez, J.C.1
Dopson, S.J.2
Sanders, D.S.3
Delay, T.A.4
Arthur, J.M.5
-
17
-
-
33751005260
-
Tolvaptan, a selective oral vasopressin V2-receptor antagonist, for hyponatremia
-
10.1056/NEJMoa065181, 17105757, Salt Investigators
-
Schrier RW, Gross P, Gheorghiade M, Berl T, Verbalis JG, Czerwiec FS, Orlandi C, . Salt Investigators Tolvaptan, a selective oral vasopressin V2-receptor antagonist, for hyponatremia. N Engl J Med 2006, 355:2099-2112. 10.1056/NEJMoa065181, 17105757, Salt Investigators.
-
(2006)
N Engl J Med
, vol.355
, pp. 2099-2112
-
-
Schrier, R.W.1
Gross, P.2
Gheorghiade, M.3
Berl, T.4
Verbalis, J.G.5
Czerwiec, F.S.6
Orlandi, C.7
-
18
-
-
0018827023
-
Treatment of the syndrome of inappropriate secretion of antidiuretic hormone by urea
-
10.1016/0002-9343(80)90506-9, 7386514
-
Decaux G, Brimioulle S, Genette F, Mockel J. Treatment of the syndrome of inappropriate secretion of antidiuretic hormone by urea. Am J Med 1980, 69:99-106. 10.1016/0002-9343(80)90506-9, 7386514.
-
(1980)
Am J Med
, vol.69
, pp. 99-106
-
-
Decaux, G.1
Brimioulle, S.2
Genette, F.3
Mockel, J.4
-
19
-
-
0020042626
-
Hyponatremia in the syndrome of inappropriate secretion of antidiuretic hormone. Rapid correction with urea, sodium chloride, and water restriction therapy
-
10.1001/jama.247.4.471, 7054549
-
Decaux G, Unger J, Brimioulle S, Mockel J. Hyponatremia in the syndrome of inappropriate secretion of antidiuretic hormone. Rapid correction with urea, sodium chloride, and water restriction therapy. JAMA 1982, 247:471-474. 10.1001/jama.247.4.471, 7054549.
-
(1982)
JAMA
, vol.247
, pp. 471-474
-
-
Decaux, G.1
Unger, J.2
Brimioulle, S.3
Mockel, J.4
-
20
-
-
0019520295
-
Urea for long-term treatment of the syndrome of inappropriate secretion of antidiuretic hormone
-
10.1136/bmj.283.6299.1081, 6794768
-
Decaux G, Genette F. Urea for long-term treatment of the syndrome of inappropriate secretion of antidiuretic hormone. Br Med J (Clin Res Ed) 1981, 283:1081-1083. 10.1136/bmj.283.6299.1081, 6794768.
-
(1981)
Br Med J (Clin Res Ed)
, vol.283
, pp. 1081-1083
-
-
Decaux, G.1
Genette, F.2
-
21
-
-
0037492960
-
Treatment of symptomatic hyponatremia
-
10.1097/00000441-200307000-00004, 12861122
-
Decaux G, Soupart A. Treatment of symptomatic hyponatremia. Am J Med Sci 2003, 326:25-30. 10.1097/00000441-200307000-00004, 12861122.
-
(2003)
Am J Med Sci
, vol.326
, pp. 25-30
-
-
Decaux, G.1
Soupart, A.2
-
22
-
-
0033768022
-
Hyponatremia in the intensive care: from diagnosis to treatment
-
Decaux G, Musch W, Soupart A. Hyponatremia in the intensive care: from diagnosis to treatment. Acta Clinica Belgica 2000, 55:68-78.
-
(2000)
Acta Clinica Belgica
, vol.55
, pp. 68-78
-
-
Decaux, G.1
Musch, W.2
Soupart, A.3
-
23
-
-
0028146515
-
Uric acid, anion gap and urea concentration in the diagnosis approach to hyponatremic patients
-
Decaux G, Schlesser M, Coffernils M, Prospert F, Namias B, Brimioulle S, Soupart A. Uric acid, anion gap and urea concentration in the diagnosis approach to hyponatremic patients. Clin Nephrol 1994, 42:102-108.
-
(1994)
Clin Nephrol
, vol.42
, pp. 102-108
-
-
Decaux, G.1
Schlesser, M.2
Coffernils, M.3
Prospert, F.4
Namias, B.5
Brimioulle, S.6
Soupart, A.7
-
24
-
-
49249137752
-
Value of fractional uric acid excretion in differential diagnosis of hyponatremic patients on diuretics
-
10.1210/jc.2008-0330, 18477658
-
Fenske W, Stork S, Koschker AC, Blechschmidt A, Lorenz D, Wortmann S, Allolio B. Value of fractional uric acid excretion in differential diagnosis of hyponatremic patients on diuretics. J Clin Endocrinol Metab 2008, 93:2991-2997. 10.1210/jc.2008-0330, 18477658.
-
(2008)
J Clin Endocrinol Metab
, vol.93
, pp. 2991-2997
-
-
Fenske, W.1
Stork, S.2
Koschker, A.C.3
Blechschmidt, A.4
Lorenz, D.5
Wortmann, S.6
Allolio, B.7
-
25
-
-
8944252996
-
Urea - new use of an old agent. Reduction of intracranial and intraocular pressure
-
Javid M. Urea - new use of an old agent. Reduction of intracranial and intraocular pressure. Surg Clin North Am 1958, 38:907-928.
-
(1958)
Surg Clin North Am
, vol.38
, pp. 907-928
-
-
Javid, M.1
-
26
-
-
76549163536
-
Blood changes on intravenous administration of mannitol or urea for reduction of intracranial pressure in neurosurgical patients
-
Buckell M. Blood changes on intravenous administration of mannitol or urea for reduction of intracranial pressure in neurosurgical patients. Clin Sci 1964, 27:223-227.
-
(1964)
Clin Sci
, vol.27
, pp. 223-227
-
-
Buckell, M.1
-
27
-
-
0009566281
-
Urea transport in the central nervous system
-
Kleeman CR, Daison H, Levin E. Urea transport in the central nervous system. Am J Physiol 1962, 203:739-747.
-
(1962)
Am J Physiol
, vol.203
, pp. 739-747
-
-
Kleeman, C.R.1
Daison, H.2
Levin, E.3
-
28
-
-
0020631460
-
Cerebral ventricular volume during hyponatremia
-
10.1136/jnnp.46.5.443, 1027395, 6101182
-
Decaux G, Szyper M, Grivegnée A. Cerebral ventricular volume during hyponatremia. J Neurol Neurosurg Psychiatry 1983, 46:443-445. 10.1136/jnnp.46.5.443, 1027395, 6101182.
-
(1983)
J Neurol Neurosurg Psychiatry
, vol.46
, pp. 443-445
-
-
Decaux, G.1
Szyper, M.2
Grivegnée, A.3
-
29
-
-
0033919512
-
Treatment of acute hyponatremia: ensuring the excretion of a predictable amount of electrolyte-free water
-
10.1097/00003246-200006000-00037, 10890640
-
Porzio P, Halberthal M, Bohn D, Halperin ML. Treatment of acute hyponatremia: ensuring the excretion of a predictable amount of electrolyte-free water. Crit Care Med 2000, 28:1905-1910. 10.1097/00003246-200006000-00037, 10890640.
-
(2000)
Crit Care Med
, vol.28
, pp. 1905-1910
-
-
Porzio, P.1
Halberthal, M.2
Bohn, D.3
Halperin, M.L.4
-
31
-
-
0031736648
-
Treating the syndrome of inappropriate secretion of ADH with isotonic saline
-
Musch W, Decaux G. Treating the syndrome of inappropriate secretion of ADH with isotonic saline. QJM 1998, 91:749-753.
-
(1998)
QJM
, vol.91
, pp. 749-753
-
-
Musch, W.1
Decaux, G.2
-
32
-
-
28844455012
-
Treatment of the polydipsia-hyponatremia syndrome with urea
-
10.4088/JCP.v66n1105, 16420073
-
Verhoeven A, Musch W, Decaux G. Treatment of the polydipsia-hyponatremia syndrome with urea. J Clin Psychiatry 2005, 66:1372-1375. 10.4088/JCP.v66n1105, 16420073.
-
(2005)
J Clin Psychiatry
, vol.66
, pp. 1372-1375
-
-
Verhoeven, A.1
Musch, W.2
Decaux, G.3
-
33
-
-
70349661390
-
Oral urea treatment for polydipsia-hyponatremia syndrome in patients with schizophrenia
-
10.1097/JCP.0b013e3181b3b38c, 19745654
-
Kawai N, Ishikawa K, Nemoto K, Katano T, Takahashi S, Hori T, Asada T. Oral urea treatment for polydipsia-hyponatremia syndrome in patients with schizophrenia. J Clin Psychopharmacol 2009, 29:499-501. 10.1097/JCP.0b013e3181b3b38c, 19745654.
-
(2009)
J Clin Psychopharmacol
, vol.29
, pp. 499-501
-
-
Kawai, N.1
Ishikawa, K.2
Nemoto, K.3
Katano, T.4
Takahashi, S.5
Hori, T.6
Asada, T.7
-
34
-
-
35649016098
-
Hyponatremia treatment guidelines 2007: expert panel recommendations
-
10.1016/j.amjmed.2007.09.001, 17981159
-
Verbalis JG, Goldsmith SR, Greenberg A, Schrier RW, Sterns RH. Hyponatremia treatment guidelines 2007: expert panel recommendations. Am J Med 2007, 120:S1-S21. 10.1016/j.amjmed.2007.09.001, 17981159.
-
(2007)
Am J Med
, vol.120
-
-
Verbalis, J.G.1
Goldsmith, S.R.2
Greenberg, A.3
Schrier, R.W.4
Sterns, R.H.5
-
35
-
-
49149116406
-
Clinical laboratory evaluation of the syndrome of inappropriate secretion of antidiuretic hormone
-
10.2215/CJN.04431007, 18434618
-
Decaux G, Musch W. Clinical laboratory evaluation of the syndrome of inappropriate secretion of antidiuretic hormone. Clin J Am Soc Nephrol 2008, 3:1175-1184. 10.2215/CJN.04431007, 18434618.
-
(2008)
Clin J Am Soc Nephrol
, vol.3
, pp. 1175-1184
-
-
Decaux, G.1
Musch, W.2
-
36
-
-
0029091287
-
Combined fractional excretion of sodium and urea better predicts response to saline in hyponatremia than do usual clinical and biochemical parameters
-
10.1016/S0002-9343(99)80180-6, 7573088
-
Musch W, Thimpont J, Vandervelde D, Vanhaeverbeke I, Berghmans T, Decaux G. Combined fractional excretion of sodium and urea better predicts response to saline in hyponatremia than do usual clinical and biochemical parameters. Am J Med 1995, 99:348-355. 10.1016/S0002-9343(99)80180-6, 7573088.
-
(1995)
Am J Med
, vol.99
, pp. 348-355
-
-
Musch, W.1
Thimpont, J.2
Vandervelde, D.3
Vanhaeverbeke, I.4
Berghmans, T.5
Decaux, G.6
-
37
-
-
0025962802
-
Limits of brain tolerance to daily increments in serum sodium in chronically hyponatremic rats treated by hypertonic saline or urea
-
Soupart A, Stenuit A, Perier O, Decaux G. Limits of brain tolerance to daily increments in serum sodium in chronically hyponatremic rats treated by hypertonic saline or urea. Clin Sci (Lond) 1991, 80:77-84.
-
(1991)
Clin Sci (Lond)
, vol.80
, pp. 77-84
-
-
Soupart, A.1
Stenuit, A.2
Perier, O.3
Decaux, G.4
-
38
-
-
0033962490
-
Azotemia (48 h) decreases the risk of brain damage in rats after correction of chronic hyponatremia
-
10.1016/S0006-8993(99)02259-3, 10661508
-
Soupart A, Penninckx R, Stenuit A, Decaux G. Azotemia (48 h) decreases the risk of brain damage in rats after correction of chronic hyponatremia. Brain Res 2000, 852:167-172. 10.1016/S0006-8993(99)02259-3, 10661508.
-
(2000)
Brain Res
, vol.852
, pp. 167-172
-
-
Soupart, A.1
Penninckx, R.2
Stenuit, A.3
Decaux, G.4
-
39
-
-
0036014924
-
Rapid (24-hour) reaccumulation of brain organic osmolytes (particularly myo-Inositol) in azotemic rats after correction of chronic hyponatremia
-
10.1097/01.ASN.0000017903.77985.CD, 12039971
-
Soupart A, Silver S, Schroeder B, Sterns R, Decaux G. Rapid (24-hour) reaccumulation of brain organic osmolytes (particularly myo-Inositol) in azotemic rats after correction of chronic hyponatremia. J Am Soc Nephrol 2002, 13:1433-1441. 10.1097/01.ASN.0000017903.77985.CD, 12039971.
-
(2002)
J Am Soc Nephrol
, vol.13
, pp. 1433-1441
-
-
Soupart, A.1
Silver, S.2
Schroeder, B.3
Sterns, R.4
Decaux, G.5
-
40
-
-
34547830282
-
Treatment of hyponatremia by urea decreases risks of brain complications in rats, a brain osmolyte contents analyses
-
10.1093/ndt/gfm138, 17395650
-
Soupart A, Schroeder B, Decaux G. Treatment of hyponatremia by urea decreases risks of brain complications in rats, a brain osmolyte contents analyses. Nephrol Dial Transplant 2007, 22:1856-1863. 10.1093/ndt/gfm138, 17395650.
-
(2007)
Nephrol Dial Transplant
, vol.22
, pp. 1856-1863
-
-
Soupart, A.1
Schroeder, B.2
Decaux, G.3
-
41
-
-
0027976776
-
Prevention of brain demyelination in rats after excessive correction of chronic hypontremia by serum sodium lowering
-
10.1038/ki.1994.23, 8127009
-
Soupart A, Penninckx R, Crenier L, Stenuit A, Perier O, Decaux G. Prevention of brain demyelination in rats after excessive correction of chronic hypontremia by serum sodium lowering. Kidney Int 1994, 45:193-200. 10.1038/ki.1994.23, 8127009.
-
(1994)
Kidney Int
, vol.45
, pp. 193-200
-
-
Soupart, A.1
Penninckx, R.2
Crenier, L.3
Stenuit, A.4
Perier, O.5
Decaux, G.6
-
42
-
-
0029914566
-
Reinduction of hyponatremia improves survival in rats with myelinolysis related neurologic symptoms
-
10.1097/00005072-199605000-00011, 8627349
-
Soupart A, Penninckx R, Stenuit A, Decaux G. Reinduction of hyponatremia improves survival in rats with myelinolysis related neurologic symptoms. J Neuropathol Exp Neurol 1996, 55:594-601. 10.1097/00005072-199605000-00011, 8627349.
-
(1996)
J Neuropathol Exp Neurol
, vol.55
, pp. 594-601
-
-
Soupart, A.1
Penninckx, R.2
Stenuit, A.3
Decaux, G.4
-
43
-
-
69549135242
-
Re-induction of hyponatremia after rapid overcorrection of hyponatremia reduces mortality in rats
-
10.1038/ki.2009.254, 19606078
-
Gankam Kengne F, Soupart A, Pochet R, Brion JP, Decaux G. Re-induction of hyponatremia after rapid overcorrection of hyponatremia reduces mortality in rats. Kidney Int 2009, 76:614-621. 10.1038/ki.2009.254, 19606078.
-
(2009)
Kidney Int
, vol.76
, pp. 614-621
-
-
Gankam Kengne, F.1
Soupart, A.2
Pochet, R.3
Brion, J.P.4
Decaux, G.5
-
44
-
-
42549144456
-
DDAVP is effective in preventing and reversing inadevertent overcorrection of hyponatremia
-
10.2215/CJN.03190807, 2390955, 18235152
-
Perianayagam A, Sterns RH, Silver SM, Grieff M, Mao R, Hix J, Konides R. DDAVP is effective in preventing and reversing inadevertent overcorrection of hyponatremia. Clin J Am Soc Nephrol 2008, 3:331-336. 10.2215/CJN.03190807, 2390955, 18235152.
-
(2008)
Clin J Am Soc Nephrol
, vol.3
, pp. 331-336
-
-
Perianayagam, A.1
Sterns, R.H.2
Silver, S.M.3
Grieff, M.4
Mao, R.5
Hix, J.6
Konides, R.7
-
45
-
-
78651242972
-
Efficacy and tolerance of vaptans compared to urea for long-term treatment of patients with SIADH: a prospective study
-
(abstract)
-
Soupart A, Decaux G. Efficacy and tolerance of vaptans compared to urea for long-term treatment of patients with SIADH: a prospective study. Acta Clinica Belgica 2009, 64:563. (abstract).
-
(2009)
Acta Clinica Belgica
, vol.64
, pp. 563
-
-
Soupart, A.1
Decaux, G.2
|